Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Veins”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02181530
What this trial is testing

Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 43
Post-approval studies (Phase 4)Study completedNCT01277302
What this trial is testing

A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

Who this might be right for
Macular Edema
Genentech, Inc. 202
Large-scale testing (Phase 3)Study completedNCT01295112
What this trial is testing

Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion

Who this might be right for
Non-Ischemic Central Retinal Vein Occlusion
Texas Retina Associates 68
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Post-approval studies (Phase 4)Study completedNCT02800642
What this trial is testing

Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

Who this might be right for
Central Retinal Vein Occlusion
Bayer 162
Testing effectiveness (Phase 2)UnknownNCT01178697
What this trial is testing

Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Shahid Beheshti University of Medical Sciences
Large-scale testing (Phase 3)Study completedNCT00000162
What this trial is testing

Branch Vein Occlusion Study

Who this might be right for
Macular DegenerationNeovascularization, PathologicVitreous Hemorrhage
National Eye Institute (NEI)
Large-scale testing (Phase 3)Ended earlyNCT00642226
What this trial is testing

Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Helse Stavanger HF 34
Not applicableStudy completedNCT04793100
What this trial is testing

Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections

Who this might be right for
Central Retinal Vein Occlusion
Fondation Ophtalmologique Adolphe de Rothschild 60
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Early research (Phase 1)UnknownNCT04120311
What this trial is testing

Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Who this might be right for
Macular EdemaRadiation RetinopathyBranch Retinal Vein Occlusion+4 more
Targeted Therapy Technologies, LLC 2
Not applicableStudy completedNCT05003258
What this trial is testing

Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Assiut University 25
Large-scale testing (Phase 3)Study completedNCT00906685
What this trial is testing

Bevacizumab for Central Retinal Vein Occlusion Study

Who this might be right for
Central Retinal Vein Occlusion
Anders Kvanta 60
Post-approval studies (Phase 4)Ended earlyNCT04707625
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

Who this might be right for
Retinal Vein Occlusion
Wake Forest University Health Sciences 17
Not applicableStudy completedNCT00002135
What this trial is testing

An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Testing effectiveness (Phase 2)UnknownNCT01044329
What this trial is testing

Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Shahid Beheshti University of Medical Sciences 90
Testing effectiveness (Phase 2)Study completedNCT04085341
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

Who this might be right for
Diabetic Macular EdemaRetina Vein Occlusion
Graybug Vision 21
Not applicableStudy completedNCT04395859
What this trial is testing

Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents

Who this might be right for
Age Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Fondation Ophtalmologique Adolphe de Rothschild 233
Testing effectiveness (Phase 2)Looking for participantsNCT07259928
What this trial is testing

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

Who this might be right for
Non-Proliferative Diabetic RetinopathyRetinal Vein Occlusion
Annexin Pharmaceuticals AB 12
Not applicableStudy completedNCT01918371
What this trial is testing

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 323
Next Page